Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Clinical trial NCT01473940 · COMPLETED
Trial details
- NCT number
- NCT01473940
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-11
- Primary completion
- 2014-10-16
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.